Joseph P Balthasar Selected Research

Joseph P Balthasar Research Topics

Disease

25	Neoplasms (Cancer) 11/2023 - 01/2002
11	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 06/2007 - 09/2002
10	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2009
7	Thrombocytopenia (Thrombopenia) 06/2007 - 09/2002
5	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 04/2005
3	Infections 01/2019 - 12/2017
3	Ovarian Neoplasms (Ovarian Cancer) 10/2011 - 05/2009
2	Body Weight (Weight, Body) 12/2007 - 08/2003
1	Necrosis 12/2022
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Community-Acquired Infections 01/2018
1	Ischemia 01/2018
1	Ascites 12/2017
1	Protein-Losing Enteropathies (Protein-Losing Enteropathy) 11/2017
1	Colitis 11/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2017
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2016
1	Diabetic Nephropathies (Diabetic Nephropathy) 05/2014
1	Weight Loss (Weight Reduction) 04/2014
1	Adenocarcinoma 01/2010
1	Hemorrhage 12/2005

Drug/Important Bio-Agent (IBA)

19	Monoclonal AntibodiesIBA 01/2023 - 01/2006
11	Carcinoembryonic AntigenIBA 01/2022 - 01/2009
10	AntigensIBA 01/2023 - 01/2009
10	Inosine Triphosphate (ITP)IBA 06/2007 - 09/2002
8	AntibodiesIBA 01/2021 - 06/2003
8	Intravenous Immunoglobulins (IVIG)FDA Link 06/2007 - 09/2002
4	Immunoglobulin G (IgG)IBA 01/2019 - 09/2002
4	Topotecan (Hycamtin)FDA LinkGeneric 04/2014 - 12/2007
3	Cytotoxins (Cytolysins)IBA 01/2023 - 03/2014
3	Trastuzumab (Herceptin)FDA Link 10/2022 - 01/2021
3	Immunotoxins (Immunotoxin)IBA 10/2022 - 01/2022
3	Gelonium multiflorum GEL proteinIBA 10/2022 - 11/2014
3	Immunoglobulins (Immunoglobulin)IBA 03/2007 - 04/2005
2	Dihydrotachysterol (AT 10)IBA 11/2023 - 09/2012
2	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 01/2022
2	Peptides (Polypeptides)IBA 01/2022 - 01/2022
2	Cell-Penetrating PeptidesIBA 01/2022 - 11/2014
2	Proteins (Proteins, Gene)FDA Link 02/2017 - 11/2014
2	Evans Blue (Blue, Evans)FDA Link 01/2016 - 09/2012
2	Coloring Agents (Dyes)IBA 01/2016 - 09/2012
2	Heparin (Liquaemin)FDA LinkGeneric 11/2014 - 12/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2012 - 05/2009
2	Liposomes (Liposome)IBA 03/2007 - 11/2005
2	Methotrexate (Mexate)FDA LinkGeneric 09/2005 - 01/2002
1	polatuzumab vedotinIBA 01/2023
1	trastuzumab-vc-MMAEIBA 01/2023
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 12/2022
1	Serine (L-Serine)FDA Link 12/2022
1	ImmunosorbentsIBA 12/2022
1	EnzymesIBA 12/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	gadobutrolIBA 01/2022
1	Cetuximab (Erbitux)FDA Link 01/2022
1	Contrast MediaIBA 01/2022
1	maleimideIBA 01/2022
1	VaccinesIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Troponin IIBA 01/2018
1	neonatal Fc receptorIBA 01/2018
1	Complement System Proteins (Complement)IBA 12/2017
1	Polysaccharides (Glycans)IBA 12/2017
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 11/2017
1	Dextrans (Dextran)FDA Link 11/2017
1	Blood Proteins (Serum Proteins)IBA 11/2017
1	Sorafenib (BAY 43-9006)FDA Link 01/2016
1	Streptozocin (Streptozotocin)FDA Link 05/2014
1	Drug CarriersIBA 03/2014
1	Carboplatin (JM8)FDA LinkGeneric 10/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2011
1	Bevacizumab (Avastin)FDA Link 10/2011
1	Surface Antigens (Surface Antigen)IBA 01/2010
1	4-O-carboxymethylascochlorinIBA 12/2007
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 12/2007
1	LipidsIBA 03/2007
1	AnticoagulantsIBA 12/2005
1	Protamines (Protamine Sulfate)FDA Link 12/2005
1	AutoantibodiesIBA 12/2005
1	Immunoglobulin Fab FragmentsIBA 09/2005

Therapy/Procedure

17	Therapeutics 01/2022 - 09/2002
5	Drug Therapy (Chemotherapy) 01/2023 - 01/2002
2	Intravenous Administration 01/2018 - 01/2006
2	Bioreactors (Bioreactor) 12/2005 - 12/2005
1	Euthanasia (Mercy Killing) 01/2022
1	Immunotherapy 03/2007
1	AMF protocol 08/2003